2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole

C201H127N15O5 — CID 157293411

IUPAC2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)cc2)cc1.c1ccc(-c2cccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)c2)cc1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6ccc7ccccc7c6)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6cccc7ccccc67)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc6ccccc6c5)o4)cc3)c3ccccc23)c1
InChIInChI=1S/2C43H27N3O.2C39H25N3O.C37H23N3O/c1-2-12-34-28(9-1)10-7-17-35(34)29-18-22-31(23-19-29)42-45-46-43(47-42)32-24-20-30(21-25-32)40-36-13-3-5-15-38(36)41(33-11-8-26-44-27-33)39-16-6-4-14-37(39)40;1-2-9-33-26-34(24-17-28(33)8-1)29-15-20-31(21-16-29)42-45-46-43(47-42)32-22-18-30(19-23-32)40-36-11-3-5-13-38(36)41(35-10-7-25-44-27-35)39-14-6-4-12-37(39)40;1-2-10-26(11-3-1)29-12-8-13-30(24-29)39-42-41-38(43-39)28-21-19-27(20-22-28)36-32-15-4-6-17-34(32)37(31-14-9-23-40-25-31)35-18-7-5-16-33(35)36;1-2-9-26(10-3-1)27-16-20-29(21-17-27)38-41-42-39(43-38)30-22-18-28(19-23-30)36-32-12-4-6-14-34(32)37(31-11-8-24-40-25-31)35-15-7-5-13-33(35)36;1-2-9-27-22-28(20-15-24(27)8-1)37-40-39-36(41-37)26-18-16-25(17-19-26)34-30-11-3-5-13-32(30)35(29-10-7-21-38-23-29)33-14-6-4-12-31(33)34/h2*1-27H;2*1-25H;1-23H
InChIKeyBBBKAXKDYITOOS-UHFFFAOYSA-N
MW2832.33 g/mol
LogP52.32
Rot. Bonds24

About 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole

2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole (PubChem CID 157293411) has the molecular formula C201H127N15O5 and a molecular weight of 2832.33 g/mol. Its IUPAC name is 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
PubChem CID157293411
Molecular FormulaC201H127N15O5
Molecular Weight2832.33 g/mol
Exact Mass2830.01
IUPAC Name2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)cc2)cc1.c1ccc(-c2cccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)c2)cc1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6ccc7ccccc7c6)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6cccc7ccccc67)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc6ccccc6c5)o4)cc3)c3ccccc23)c1
InChIInChI=1S/2C43H27N3O.2C39H25N3O.C37H23N3O/c1-2-12-34-28(9-1)10-7-17-35(34)29-18-22-31(23-19-29)42-45-46-43(47-42)32-24-20-30(21-25-32)40-36-13-3-5-15-38(36)41(33-11-8-26-44-27-33)39-16-6-4-14-37(39)40;1-2-9-33-26-34(24-17-28(33)8-1)29-15-20-31(21-16-29)42-45-46-43(47-42)32-22-18-30(19-23-32)40-36-11-3-5-13-38(36)41(35-10-7-25-44-27-35)39-14-6-4-12-37(39)40;1-2-10-26(11-3-1)29-12-8-13-30(24-29)39-42-41-38(43-39)28-21-19-27(20-22-28)36-32-15-4-6-17-34(32)37(31-14-9-23-40-25-31)35-18-7-5-16-33(35)36;1-2-9-26(10-3-1)27-16-20-29(21-17-27)38-41-42-39(43-38)30-22-18-28(19-23-30)36-32-12-4-6-14-34(32)37(31-11-8-24-40-25-31)35-15-7-5-13-33(35)36;1-2-9-27-22-28(20-15-24(27)8-1)37-40-39-36(41-37)26-18-16-25(17-19-26)34-30-11-3-5-13-32(30)35(29-10-7-21-38-23-29)33-14-6-4-12-31(33)34/h2*1-27H;2*1-25H;1-23H
InChIKeyBBBKAXKDYITOOS-UHFFFAOYSA-N
XLogP52.32
TPSA259.05 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds24
Heavy Atoms221
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002832.33
LogP ≤ 552.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9,10-bis(3-naphthalen-1-ylphenyl)anthracene;9,10-bis(3-naphthalen-2-ylphenyl)anthracene;9,10-bis(4-naphthalen-1-ylphenyl)anthracene;9,10-bis(4-naphthalen-2-ylphenyl)anthracene;9-(3-naphthalen-1-ylphenyl)-10-(4-phenylphenyl)anthracene;9-(3-naphthalen-2-ylphenyl)-10-(4-phenylphenyl)anthracene;9-(4-naphthalen-1-ylphenyl)-10-(3-phenylphenyl)anthracene
CID 161131758
9-(4-naphthalen-1-ylphenyl)-10-[3-(6-phenylnaphthalen-2-yl)phenyl]anthracene
CID 58856435
9-(4-naphthalen-1-ylphenyl)-10-(4-naphthalen-2-ylphenyl)anthracene;9-(4-naphthalen-1-ylphenyl)-10-[3-(4-naphthalen-2-ylphenyl)phenyl]anthracene
CID 159854260
9,10-bis(3-naphthalen-1-ylphenyl)anthracene;9,10-bis(3-naphthalen-2-ylphenyl)anthracene;9-(3-naphthalen-1-ylphenyl)-10-(4-phenylphenyl)anthracene;9-(3-naphthalen-2-ylphenyl)-10-(4-phenylphenyl)anthracene
CID 159387221
9-(3-naphthalen-2-ylphenyl)-10-[6-(4-naphthalen-1-ylphenyl)naphthalen-2-yl]anthracene
CID 123921245
9-[3-(6-naphthalen-2-ylnaphthalen-2-yl)phenyl]-10-(4-naphthalen-1-ylphenyl)anthracene
CID 58856463
2-[4-(10-isoquinolin-6-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole
CID 59501416
10-(3-naphthalen-2-ylphenyl)-9-(4-naphthalen-1-ylphenyl)-2-phenylanthracene
CID 58323266
2-naphthalen-1-yl-10-(4-naphthalen-1-ylphenyl)-9-phenylanthracene;2-naphthalen-1-yl-10-(4-naphthalen-2-ylphenyl)-9-phenylanthracene;2-naphthalen-2-yl-10-(4-naphthalen-2-ylphenyl)-9-phenylanthracene;9-phenyl-10-[4-(3-phenylphenyl)phenyl]anthracene;9-phenyl-10-[4-[3-(3-phenylphenyl)phenyl]phenyl]anthracene
CID 158805732
9-(4-naphthalen-1-ylphenyl)-10-[4-(3-phenylphenyl)phenyl]anthracene
CID 59398966
bis(9-(3-naphthalen-1-ylphenyl)-10-[4-[10-(3-naphthalen-1-ylphenyl)anthracen-9-yl]phenyl]anthracene);9-(4-naphthalen-2-ylphenyl)-10-[4-[10-(4-naphthalen-2-ylphenyl)anthracen-9-yl]phenyl]anthracene;9-(2-phenylphenyl)-10-[4-[10-(2-phenylphenyl)anthracen-9-yl]phenyl]anthracene;9-[2-(4-phenylphenyl)phenyl]-10-[4-[10-[2-(4-phenylphenyl)phenyl]anthracen-9-yl]phenyl]anthracene
CID 160597374
9-naphthalen-1-yl-10-[4-(4-naphthalen-1-ylnaphthalen-1-yl)phenyl]anthracene;9-naphthalen-1-yl-10-[4-(4-naphthalen-2-ylnaphthalen-1-yl)phenyl]anthracene;9-naphthalen-1-yl-10-[4-(6-naphthalen-1-ylnaphthalen-2-yl)phenyl]anthracene;9-naphthalen-1-yl-10-[4-(6-naphthalen-2-ylnaphthalen-2-yl)phenyl]anthracene;9-(4-naphthalen-1-ylnaphthalen-1-yl)-10-(4-naphthalen-1-ylphenyl)anthracene;9-(4-naphthalen-2-ylnaphthalen-1-yl)-10-(4-naphthalen-1-ylphenyl)anthracene;9-naphthalen-1-yl-10-[4-(4-phenylnaphthalen-1-yl)phenyl]anthracene;9-naphthalen-1-yl-10-[4-(6-phenylnaphthalen-2-yl)phenyl]anthracene;9-(4-naphthalen-1-ylphenyl)-10-(4-phenylnaphthalen-1-yl)anthracene;9-naphthalen-1-yl-10-[4-(3-phenylphenyl)phenyl]anthracene
CID 159304855

Frequently Asked Questions

What is the IUPAC name of 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The IUPAC name of 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole (CID 157293411) is 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole is c1ccc(-c2ccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)cc2)cc1.c1ccc(-c2cccc(-c3nnc(-c4ccc(-c5c6ccccc6c(-c6cccnc6)c6ccccc56)cc4)o3)c2)cc1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6ccc7ccccc7c6)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc(-c6cccc7ccccc67)cc5)o4)cc3)c3ccccc23)c1.c1cncc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccc6ccccc6c5)o4)cc3)c3ccccc23)c1.
What is the InChIKey of 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The InChIKey is BBBKAXKDYITOOS-UHFFFAOYSA-N. The full InChI is InChI=1S/2C43H27N3O.2C39H25N3O.C37H23N3O/c1-2-12-34-28(9-1)10-7-17-35(34)29-18-22-31(23-19-29)42-45-46-43(47-42)32-24-20-30(21-25-32)40-36-13-3-5-15-38(36)41(33-11-8-26-44-27-33)39-16-6-4-14-37(39)40;1-2-9-33-26-34(24-17-28(33)8-1)29-15-20-31(21-16-29)42-45-46-43(47-42)32-22-18-30(19-23-32)40-36-11-3-5-13-38(36)41(35-10-7-25-44-27-35)39-14-6-4-12-37(39)40;1-2-10-26(11-3-1)29-12-8-13-30(24-29)39-42-41-38(43-39)28-21-19-27(20-22-28)36-32-15-4-6-17-34(32)37(31-14-9-23-40-25-31)35-18-7-5-16-33(35)36;1-2-9-26(10-3-1)27-16-20-29(21-17-27)38-41-42-39(43-38)30-22-18-28(19-23-30)36-32-12-4-6-14-34(32)37(31-11-8-24-40-25-31)35-15-7-5-13-33(35)36;1-2-9-27-22-28(20-15-24(27)8-1)37-40-39-36(41-37)26-18-16-25(17-19-26)34-30-11-3-5-13-32(30)35(29-10-7-21-38-23-29)33-14-6-4-12-31(33)34/h2*1-27H;2*1-25H;1-23H.
What are the key properties of 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole has a molecular weight of 2832.33 g/mol, XLogP of 52.32, 24 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-naphthalen-1-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-naphthalen-2-ylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-naphthalen-2-yl-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(3-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-(4-phenylphenyl)-5-[4-(10-pyridin-3-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 157293411), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).